Researchers set out to resolve why two structurally similar small molecule kinase inhibitors exhibit different lifetime of the drug-target complex with their target protein kinase.
![](https://mb.cision.com/Public/9798/3494364/a9f1823773d8ba5e_800x800ar.png)
Photographer: Tatu Pantsar
In the study, researchers set out to resolve why two structurally similar small molecule kinase inhibitors (red and blue) exhibit different lifetime of the drug-target complex with their target protein kinase (white).